Profil Penggunaan Antibiotik dengan Metode Defined Daily Dose pada Pasien Pneumonia Rawat Inap Salah Satu Rumah Sakit Swasta Tipe C di Minahasa
DOI:
https://doi.org/10.35790/ecl.v12i3.58563Abstract
Abstract: The high prevalence of pneumonia cases in Indonesia affects the increasing use of antibiotics, which can lead to resistance. The defined daily dose (DDD) method can be utilized to improve the quality of antibiotic use by enabling quantitative evaluation. This study aimed to determine the quantity of antibiotic use in pneumonia inpatients at type C private hospital in Minahasa from July 2022 to June 2023. This was a descriptive and retrospective study using secondary data of medical records of pneumonia inpatients that were calculated using the DDD method. The results obtained 45 pneumonia patients received antibiotic therapy. The highest usage antibiotic was ceftriaxone with 46.09 DDD/100 bed days. In conclusion, the administration of antibiotics for treatment was appropriate, however, there is a need to develop clinical pathway to provide a structured guidelines for patient management.
Keywords: antibiotics; pneumonia; defined daily dose
Abstrak: Tingginya kasus pneumonia di Indonesia memengaruhi peningkatan penggunaan antibiotik yang dapat menyebabkan kejadian resistensi. Metode defined daily dose (DDD) dapat digunakan untuk meningkatkan kualitas penggunaan antibiotik yakni dengan melakukan evaluasi secara kuantitatif. Penelitian ini bertujuan untuk mengetahui kuantitas penggunaan antibiotik pada pasien pneumonia rawat inap salah satu rumah sakit swasta Tipe C di Minahasa periode Juli 2022 - Juni 2023. Jenis penelitian ialah deskriptif dengan pendekatan retrospektif menggunakan data sekunder berupa rekam medis pasien yang selanjutnya dihitung dengan menggunakan metode DDD. Hasil penelitian mendapatkan 45 pasien pneumonia yang menerima terapi antibiotik. Antibiotik dengan jumlah penggunaan tertinggi yakni ceftriaxone dengan nilai sebesar 46,09 DDD/100 bed days. Simpulan penelitian ini ialah secara keseluruhan pemberian antibiotik dalam pengobatan sesuai, namun perlu dilakukan pembuatan clinical pathway agar penanganan bagi setiap pasien dapat memiliki panduan yang terstruktur.
Kata kunci: antibiotik; pneumonia; defined daily dose
References
Jain V, Vashisht R, Yilmaz G, Bhardwaj A. Pneumonia Pathology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. 2023 Jul 31. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK526116/
Menteri Kesehatan RI. Pedoman nasional pelayanan kedokteran tata laksana pneumonia pada dewasa. 2023. Available from: https://www.kemkes.go.id/id/pnpk-2023---tata-laksana-pneumonia-pada-dewasa
Permenkes RI. Pedoman penggunaan antibiotik. 2021; p. 1–97. Available from: https://yankes.kemkes.go.id/ unduhan/fileunduhan_1658480966_921055.pdf
World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for atc classification and ddd assignment 2023 (26th ed). Oslo; 2022. Available from: https://www.whocc.no/ filearchive/publications/2023_guidelines_web.pdf
Prasetyo EY, Kusumaratni DA. Evaluasi penggunaan antibiotik pada pasien pneumonia rawat inap di RS DKT Kota Kediri dengan metode ATC DDD tahun 2018. Prosiding Seminar Nasional Farmasi Institut Ilmu Kesehatan Bhakti Wiyata Kediri 2018. Available from: https://prosidingonline.iik.ac.id/index.php/ semfarm/article/view/124/122
Nelita P, Permatasari J, Meirista I. Evaluasi penggunaan antibiotik pada pasien pneumonia di Rumah Sakit Umum Daerah Abdul Manap Jambi menggunakan metoda Gyssens. Jurnal Impresi Indonesia. 2022;1(7):786–790. Available from: https://jii.rivierapublishing.id/index.php/jii/article/view/213
López-de-Andrés A, Albaladejo-Vicente R, de Miguel-Diez J, Hernández-Barrera V, Ji Z, Zamorano-León JJ, et al. Gender differences in incidence and in-hospital outcomes of community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in Spain. International Journal of Clinical Practice. 2021;75(3):e13762. Doi:10.1111/IJCP.13762
Herawati F, Ilmi T, Yulia R. Profil penggunaan antibiotik dan peta kuman pada pasien pneumonia di ruang pulmonary RSUD Dr. Iskak Tulungangung. Intisari Sains Medis. 2019;7, Available from: https://digilib.ubaya.ac.id/index.php?page=view/daftarpustaka_detail&key=249579
Lim WS. Pneumonia (2nd ed). Elsevier. Nottingham: Nottingham University Hospitals NHS Trust and University of Nottingham; 2022. Doi: https://doi.org/10.1016/B978-0-12-801238-3.11636-8
Li HK, Agweyu A, English M, Bejon P. An unsupported preference for intravenous antibiotics. Plos Med. 2015;12(5):1–7. Doi: 10.1371/journal.pmed.1001825
Watupongoh HH, Kusumawati DS. Malnutrisi sebagai faktor risiko pneumonia nosokomial pada usia lanjut. Majalah Kedokteran UKI. 2023;37(2):58-67. 2021. Available from: https://doi.org/10.33541 /mk.v37i2.4825
Puspita T, Dhirisma F. Penggunaan antibiotika pada pasien dewasa pneumonia dengan metode DDD di Rawat Inap RSU PKU Muhammadiyah Bantul periode tahun 2019. Jurnal Kefarmasian Akfarindo. 2021;6(1):8-13. Available from: https://jofar.afi.ac.id/index.php/jofar/article/view/97
Fatin MNA, Rahayu C, Suwantika AA. Analisis efektivitas biaya penggunaan antibiotik pada pasien community-acquired pneumonia di RSUP Dr. Hasan Sadikin Bandung. Indonesian Journal of Clinical Pharmacy. 2019;8(3):228-36. Available from: https://jurnal.unpad.ac.id/ijcp/article/view/22428/pdf
Widasari N. Pola derajat keparahan pneumonia dan terapi antibiotik empirik pada pasien community-acquired pneumonia yang dirawat di RSUP Dr. Kariadi Semarang [Skripsi]. Semarang: Universitas Diponegoro; 2014. Available from: https://www.neliti.com/publications/138353/pola-derajat-keparahan-pneumonia-dan-terapi-antibiotik-empirik-pada-pasien-commu
Prasetya AANPR, Wijaya IGEJS, Kurnianta PDM. Evaluasi penggunaan antibiotik dengan metode ATC/DDD dan DU90% pada pasien pneumonia di RSD X tahun 2022. Jurnal Mandala Pharmacon Indonesia. 2023;9(2):408-18. Available from: https://jurnal-pharmaconmw.com/jmpi/index.php/jmpi/article/view/398
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Santi Clara, Edward Nangoy, Jimmy Posangi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
